Logotype for Zenicor

Zenicor (ZENI) investor relations material

Zenicor Investor Update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Zenicor
Investor Update summary4 Nov, 2025

Business overview and market positioning

  • Specializes in cardiology, focusing on arrhythmia diagnostics with medical-grade systems and services for professional healthcare.

  • Solutions include hardware (Zenicor One, Zenicor Flex), software (Zenicor View), and service packages (Zenicor Direct) for EKG analysis and logistics.

  • Over 300 hospitals and clinics in Northern Europe use the solutions, with main markets in Sweden, Finland, Norway, and the UK.

  • Business model offers both pay-per-assessment and license-based revenue streams, adaptable to local reimbursement systems.

  • Focus on early diagnosis to reduce healthcare costs and improve patient outcomes.

Clinical impact and scientific validation

  • Products are certified for professional healthcare and supported by over 50 clinical studies.

  • Studies show high diagnostic accuracy and significant reduction in stroke risk when using the solutions.

  • Screening programs, such as Stroke Stop and SAFER, demonstrate increased detection of atrial fibrillation and potential healthcare savings.

  • Ongoing large-scale studies in the UK (SAFER) and Australia aim to further validate the benefits of arrhythmia screening.

  • Health economic analyses indicate substantial cost savings and improved patient quality of life.

Growth strategy and market expansion

  • Targeting a fourfold increase in arrhythmia investigations per capita, aiming to grow from 5 to 20 per 1,000 inhabitants annually.

  • Expansion driven by simplified care chains (e.g., Värmland model) and increased screening in risk populations.

  • Recent contract wins include Region Dalarna, doctor.se, and NHS in the UK, with more regional tenders expected in Sweden and Finland.

  • Focus remains on existing markets due to strong reimbursement systems and significant untapped potential.

  • Private clinics and direct sales complement public sector contracts.

Elaborate on current market growth drivers
SAFER study: When is stroke reduction data expected?
Confidence in winning 2-3 tenders for 35M SEK?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Zenicor earnings date

Logotype for Zenicor
Q4 202513 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Zenicor earnings date

Logotype for Zenicor
Q4 202513 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Zenicor Medical Systems AB is a Sweden-based medical technology company specializing in solutions for cardiac diagnostics. The company’s flagship product, Zenicor-EKG, is an innovative handheld device designed for the detection and monitoring of heart conditions such as atrial fibrillation. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage